Key result
Azilsartan medoxomil supports chlorthalidone combination for hypertension via strong AT1 binding and improved insulin sensitivity.
Why the study?
What are the pharmacological properties and clinical rationale for using azilsartan medoxomil and its fixed combination with chlorthalidone in patients with arterial hypertension?
What are the pharmacological properties and clinical rationale for using azilsartan medoxomil and its fixed combination with chlorthalidone in patients with arterial hypertension?
Azilsartan medoxomil possesses unique pharmacological properties, including strong AT1 receptor binding and insulin-sensitizing effects, which provide a rationale for its use in hypertension management, particularly in combination with chlorthalidone.
The article discusses the factors that determine the choice of antihypertensive drugs, especially blockers of receptors of angiotensin and thiazide diuretics. The data about the peculiarities of azilsartan medoxomil, it differs from other sartans. Among the main properties of azilsartan medoxomil, which may determine his choice for the treatment of patients with arterial hypertension, is called the significant strength of the binding of blockers of receptors of angiotensin to AT1 receptor and its duration of action, as well as special properties that improve tissue sensitivity to insulin. Discussed the feasibility of establishing fixed combinations azilsartan medoxomil with thiazide diuretics chlorthalidone.
No takes yet. Share an insight, caveat, or question.
Кislyak et al. (2015) conducted a review in arterial hypertension. azilsartan medoxomil and chlorthalidone was evaluated. Azilsartan medoxomil offers strong AT1 receptor binding, long duration of action, and improved insulin sensitivity, supporting its fixed combination with chlorthalidone for arterial hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: